Search results
Sapiens (SPNS) Benefits From a Strong Portfolio, Partner Base
Zacks via Yahoo News· 3 hours agoThe Zacks Consensus Estimate for 2024 revenues is pegged at $553.45 million, indicating...
Save up to 70% on the best July 4th sales from Amazon, Walmart, Target and more
Yahoo Life Shopping· 2 hours agoMilitary personnel, teachers and healthcare workers receive an extra 5% off their order. Cocoon by...
5 S&P 500 Banks That Outperformed the Index in the First Half
Zacks via Yahoo News· 1 day agoInvestors remain bullish on bank stocks in the first half of 2024, driven by rate cut expectations,...
5 Top-Performing High-Dividend ETFs of 1H 2024
Zacks via Yahoo News· 2 days ago55% The ETF is actively managed and looks to achieve its investment objective by investing at least 80% of its total assets in equity...
Interactive Brokers (IBKR) Reports Rise in June Client DARTs
Zacks via Yahoo News· 3 hours agoBrokers’ total options contracts were 98.8 million in June 2024, up 18.9% year over year but down 5%...
Walking trails, trains and outdoor activities: A guide to exploring Italy sustainably
Euronews via Yahoo News· 2 hours agoHow is Italy promoting sustainable tourism? Tour company Walks of Italy reports Italy has 55 UNESCO...
Why Is Agilent (A) Down 0.5% Since Last Earnings Report?
Zacks via Yahoo News· 5 days agoThe company also revised fiscal 2024 non-GAAP earnings per share guidance downward from $5.44-$5.55...
5 things to know for June 28: Debate recap, Religious freedom, Uvalde, Mobile outage, Peru...
CNN via Yahoo News· 5 days agoThe company said it was working to restore full service but did not elaborate on the cause of the...
Tutor Perini (TPC) and O&G JV Wins Amtrak Bridge Project
Zacks via Yahoo News· 3 hours agoNavy projects in Diego Garcia and an additional $52-million funding for three...HWM sports a Zacks...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo News· 5 hours agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...